Which superinvestors hold Teva Pharmaceutical-Sp Adr (TEVA)?

Per the latest SEC 13F filings, 4 superinvestors hold Teva Pharmaceutical-Sp Adr (TEVA): Harry Burn, David Einhorn, Ray Dalio, Stanley Druckenmiller. Combined value held is about $292.8M, with Harry Burn the largest holder.

← Stocks

Teva Pharmaceutical-Sp Adr

TEVA

Held by 4 superinvestors.

Price$37.92

Holders4

Total value$292.8M

SEC 10-K · fundamentals

Business quality

as of 2025-12-31

Valuation basis: trailing twelve months to 2026-06-30 — latest 10-K plus unaudited 10-Q filings.

Revenue growth: +4.3%
Net margin: 8.2%
ROE: 17.8%
FCF margin: 6.7%

Revenue $16.66B → $17.26B · 6y

What makes a business high quality

SEC 13F · holders

Superinvestors Holding This Security

4 holders · $292.8M combined · this quarter +0 opened / -0 exited

This quarter1 added3 trimmed

Holders 9 → 4 · last 8q

Investor	Value	Shares	Weight (prev→now)
Harry Burn	$128.9M	3,804,497	3.9% → 4.0% ▲
David Einhorn	$97.8M	2,886,059	2.7% → 2.5% ▼
Ray Dalio	$44.9M	1,326,678	0.2% → 0.2% ▲
Stanley Druckenmiller	$21.2M	624,999	2.4% → 0.5% ▼

Harry Burn
Value$128.9MWeight (prev→now)3.9% → 4.0% ▲
David Einhorn
Value$97.8MWeight (prev→now)2.7% → 2.5% ▼
Ray Dalio
Value$44.9MWeight (prev→now)0.2% → 0.2% ▲
Stanley Druckenmiller
Value$21.2MWeight (prev→now)2.4% → 0.5% ▼

SEC 13F · notes

Written summary

Teva Pharmaceutical-Sp Adr (TEVA) is held by 4 of the superinvestors tracked on Compounder, with a combined $292.8M in reported 13F value. The largest position belongs to Harry Burn, where it makes up 4.0% of the portfolio.

Other notable holders by value include David Einhorn (2.5% of its book), Ray Dalio (0.2% of its book) and Stanley Druckenmiller (0.5% of its book).

Over the latest quarter, 0 of the tracked filers opened a new position in TEVA, 1 added to existing ones, 3 trimmed, and 0 sold out entirely.

Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-06-30. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.

How to read a 13F

SEC 13F · co-ownership

Also held by these investors

Investors holding Teva Pharmaceutical-Sp Adr (TEVA) also commonly hold →

Amazon.Com IncAMZN3 holders
Alphabet Inc-Cl AGOOGL3 holders
Fluor CorpFLR3 holders
Thermo Fisher Scientific IncTMO3 holders
Natera IncNTRA2 holders
Lam Research CorpLRCX2 holders

See which stocks look cheap against a conservative value band. Browse all valued stocks

Also on

Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-14

Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.

Stay Updated

New-quarter 13F moves and valuation updates, to your inbox.